Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study-Reference-Cited by-同舟云学术

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study

Published:2020-10-02 Issue:3 Volume:35 Page:677-684
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Richard M.‐A.¹²^ORCID,Lacour J.‐P.³^ORCID,Konstantinou M.‐P.⁴^ORCID,Ruer‐Mulard M.⁵,Joly P.⁶^ORCID,Aractingi S.⁷,Auquier P.¹⁸,Pelvet B.⁹,Augustin M.L.⁹,Mahé E.¹⁰^ORCID,Chalmers R.J.G.¹¹

Affiliation:

1. CEReSS‐EA 3279 Research Centre in Health Services and Quality of Life Aix Marseille University Marseille France

2. Department of Dermatology University Hospital Timone Marseille APHM Marseille France

3. Department of Dermatology University Hospital of Nice Archet‐2 Hospital Nice France

4. Department of Dermatology Larrey Hospital and Paul Sabatier University Toulouse France

5. Private Office Martigues France

6. Department of Dermatology Rouen University Hospital University of Rouen Normandie Rouen France

7. Department of Dermatology Cochin‐Tarnier Hospital Paris France

8. Department of Public Health University Hospital Timone MarseilleAPHM Marseille France

9. R&D, Novartis Pharma SAS Rueil‐Malmaison France

10. Department of Dermatology Victor Dupouy Hospital Argenteuil France

11. Centre for Dermatology University of Manchester Manchester UK

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16893

Reference21 articles.

1. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument

2. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

3. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

4. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)

5. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of serum level of squamous cell carcinoma antigen with severity of cutaneous psoriasis, assessed using the simplified psoriasis index;Annales de Dermatologie et de Vénéréologie;2024-03

2. [Translated article] Translation into Spanish and Field-Testing of a New Score for Evaluating Psoriasis Severity: The Simplified Psoriasis Index (SPI);Actas Dermo-Sifiliográficas;2022-04

3. Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches;Oxidative Medicine and Cellular Longevity;2022-03-12

4. PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI;Australasian Journal of Dermatology;2021-11-10

5. Les critères d’efficacité pour l’évaluation de la réussite du traitement;Annales de Dermatologie et de Vénéréologie - FMC;2021-10